Regnase-1 inhibitors therapy(Ribometrix)

N/A

Report date: 2024/09/04 16:25:16

Base Information

Drug NameRegnase-1 inhibitors therapy(Ribometrix)

Drug Alias NameN/A

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionRNA modulatorsRegnase-1 inhibitors

TargetsRibonucleic AcidRegnase-1

Therapy Area/IndicationsImmune System Diseases

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesRibometrix Inc

China Registration ClassN/A

Active CompaniesRibometrix Inc

Inactive CompaniesN/A

Active IndicationsImmune System Diseases

Inactive IndicationsN/A

ATC CodeN/A